Last edition
News about "Cardiometabolic indications"
Julius Clinical Strengthens CNS and Cardiometabolic Expertise, Adds Operations in Spain and Germany
Julius Clinical has reported strong Q2 2025 growth in CNS and Cardiometabolic bookings, driven by its merger with Peachtree BioResearch Solutions and expanded operations in Spain and Germany.
Cardiometabolic Indications | 04/09/2025 | By Mrinmoy Dey
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members